Caris Life Sciences raises $150 mln
Caris Life Sciences said Oct. 1 that it raised $150 million in growth capital in the form of senior secured debt and convertible notes from TPG Sixth Street Partners. Caris, of Irving, Texas, is developing next generation profiling of the whole genome, whole transcriptome and the complete cancer proteome.
1 October 2018•4 mins read
